We are monitoring the impact of COVID-19 on North America Nanomedicine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6248
Share on
Share on

North America Nanomedicine Market Research Report - Segmented By Product, Disease Type, Nano molecule Type and Country (the United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Trends and Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 6248
Pages: 145

North America Nanomedicine Market Size (2021 to 2026)

The size of the Nanomedicine market in North America is valued at USD 59.86 billion in 2021. This value is projected to grow at a CAGR of 11.5% to reach USD 103.17 billion by 2026. The Global nanomedicine market was dominated by North America in 2021 and accounted for a market share of 42%.

The growing aging population in North America, Y-O-Y growth in the incidence of chronic diseases, particularly obesity, kidney disorders, cancer, diabetes, and orthopedic diseases, are majorly propelling the market growth. Growing funds and investments from governments and private organizations, and raising awareness regarding the Nanomedicine applications are likely to drive the market during the estimated period. Furthermore, the focus of key players on the R &D and wide range of Nanomedicine applications such as oncology, cardiovascular, neurology, anti-infective, and other areas are further fueling the Nanomedicine market in North America.

High costs associated with the Nanomedicine, lengthy approval process, and lack of knowledge regarding the Nanomedicine treatment options with this medicine are majorly restraining the market growth.

This research report on the North America Nanomedicine Market has been segmented and sub-segmented into the following categories:

By Product:

  • Diagnostic Imaging               
  • Regenerative Medicine     
  • Drug Delivery         
  • Implants  
  • Vaccines  
  • Others

By Disease Type:

  • Cardiovascular Diseases    
  • Neurological Diseases        
  • Ophthalmological Diseases              
  • Infectious Diseases             
  • Immunological Diseases    
  • Orthopedic Disorders         
  • Oncological Diseases           
  • Others     

By Nanomolecule Type:

  • Nanotubes
  • Nanoparticles
  • Nanodevices
  • Nanoshells
  • Others

By Country: 

  • The United States
  • Canada
  • Rest of North America

North America leads the Nanomedicine market due to the huge investments in nanomedicine research from government organizations in the United States. Due to the highly developed healthcare infrastructure and high incidence of cancer, nanomedicine is readily adopted.

The North America nanomedicine market is estimated to dominate by the U.S. during the forecast period due to the developing technology for drug delivery, growing acquisition for Nanomedicines, government steps taken towards enhancing healthcare facilities, and the insurance schemes are considered to fuel the market. Obtaining Nano-medicine in R&D activities of drugs for COVID-19 is expected to take the market growth to the next level in the coming years.

The Nanomedicine market for Canada is witnessed to have rapid growth over the analysis period due to Nanorobotics' existence, and these Nano-medicines are cost-effective. Enhancements over the biodegradable Nanoparticles growing applications like Nano-capsules and Nano-tubes for drug delivery systems, availability of skilled labor in manufacturing these drugs are expected to provide support for the market growth in Canada.

Companies playing a dominant role in the North America Nanomedicine Market profiled in this report are Johnson & Johnson, Merck & Co, Pfizer, Abbott Laboratories, GE Healthcare, Celgene Corporation, Nanosphere, Inc, Gilead Sciences, Hoffmann-La Roche, Nanospectra Biosciences, and Arrowhead Pharmaceuticals.

1.Introduction         

                1.1 Market Definition      

                1.2 Study Deliverables    

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions  

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases        

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary  

                3.2 Key Inferences

                3.3 Epidemology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints      

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Product          

                                5.1.1 Introduction                                           

                                5.1.2 Diagnostic Imaging 

                                5.1.3 Regenerative Medicine                                     

                                5.1.4 Drug Delivery                                         

                                5.1.5 Implants                                   

                                5.1.6 Vaccines                                   

                                5.1.7 Others                                      

                                5.1.8  Y-o-Y Growth Analysis, By Product                                              

                                5.1.9  Market Attractiveness Analysis, By Product                                            

                                5.1.10  Market Share Analysis, By Product                                            

                5.2 Disease Type    

                                5.2.1 Introduction                                           

                                5.2.2 Cardiovascular Diseases                                    

                                5.2.3 Neurological Diseases                                        

                                5.2.4 Ophthalmological Diseases

                                5.2.5 Infectious Diseases                                             

                                5.2.6 Immunological Diseases                                    

                                5.2.7 Orthopedic Disorders                                         

                                5.2.8 Oncological Diseases                                           

                                5.2.9 Others                                      

                                5.2.10 Y-o-Y Growth Analysis, By Disease Type                                  

                                5.2.11 Market Attractiveness Analysis, By Disease Type  

                                5.2.12 Market Share Analysis, By Disease Type                                  

                5.3 Nanomolecule Type      

                                5.3.1 Introduction                                           

                                5.3.2 Nanotubes

                                5.3.3 Nanoparticles                                        

                                5.3.4 Nanodevices                                          

                                5.3.5 Nanoshells

                                5.3.6 Others                                      

                                5.3.7 Y-o-Y Growth Analysis, By Nanomolecule Type                                       

                                5.3.8  Market Attractiveness Analysis, By Nanomolecule Type                                    

                                5.3.9  Market Share Analysis, By Nanomolecule Type                                     

6. Geographical Analysis                     

                6.1 Introduction      

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

  6.1.3.1 By Geographical Area                     

  6.1.3.2 By Product                           

  6.1.3.3 By Disease Type                

  6.1.3.4 By Nanomolecule Type                  

                                6.1.4  Market Attractiveness Analysis                                     

  6.1.4.1 By Geographical Area                     

  6.1.4.2 By Product                           

  6.1.4.3 By Disease Type                

  6.1.4.4 By Nanomolecule Type                  

                                6.1.5  Market Share Analysis                                      

  6.1.5.1 By Geographical Area                     

  6.1.5.2 By Product                           

  6.1.5.3 By Disease Type                

  6.1.5.4 By Nanomolecule Type                  

                6.2 United States   

                6.3 Canada           

7. Strategic Analysis              

                7.1 PESTLE analysis

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis     

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis               

                8.1 Johnson & Johnson   

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Merck & Co  

                8.3 Pfizer   

                8.4 Abbott Laboratories      

                8.5 GE Healthcare  

                8.6 Celgene Corporation     

                8.7 Nanosphere, Inc        

                8.8 Gilead Sciences

                8.9 Hoffmann-La Roche  

                8.10 Nanospectra Biosciences     

                8.11 Arrowhead Pharmaceuticals    

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis         

                9.3 Agreements, collaborations and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables  

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Product Type, by Disease type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. North America Nanomedicine Market, By Product, From 2021 to 2026 (USD Billion)
  2. North America Diagnostic Imaging Market, By Region, From 2021 to 2026 (USD Billion)
  3. North America Regenerative Medicine Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Drug Delivery Market, By Region, From 2021 to 2026 (USD Billion)
  5. North America Implants Market, By Region, From 2021 to 2026 (USD Billion)
  6. North America Vaccines Market, By Region, From 2021 to 2026 (USD Billion)
  7. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  8. North America Nanomedicine Market, By Disease Type, From 2021 to 2026 (USD Billion)
  9. North America Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  10. North America Neurological Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  11. North America Ophthalmological Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  12. North America Infectious Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  13. North America Immunological Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  14. North America Orthopedic Disorders Market, By Region, From 2021 to 2026 (USD Billion)
  15. North America Oncological Diseases Market, By Region, From 2021 to 2026 (USD Billion)
  16. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  17. North America Nanomedicine Market, By Nanomolecule Type, From 2021 to 2026 (USD Billion)
  18. North America Nanotubes Market, By Region, From 2021 to 2026 (USD Billion)
  19. North America Nanoparticles Market, By Region, From 2021 to 2026 (USD Billion)
  20. North America Nanodevices Market, By Region, From 2021 to 2026 (USD Billion)
  21. North America Nanoshells Market, By Region, From 2021 to 2026 (USD Billion)
  22. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  23. United States Nanomedicine Market, By Product, From 2021 to 2026 (USD Billion)
  24. United States Nanomedicine Market, By Disease Type, From 2021 to 2026 (USD Billion)
  25. United States Nanomedicine Market, By Nanomolecule Type, From 2021 to 2026 (USD Billion)
  26. Canada Nanomedicine Market, By Product, From 2021 to 2026 (USD Billion)
  27. Canada Nanomedicine Market, By Disease Type, From 2021 to 2026 (USD Billion)
  28. Canada Nanomedicine Market, By Nanomolecule Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample